3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
1
Sezary Syndrome
1
Sarcoma
1
Paget Disease, Extramammary
1
Neurofibromatosis 1
1
Neurofibromatoses
1
Neurofibroma
1
Mycosis Fungoides
1
Muir-Torre Syndrome
1
Microcystic adnexal carcinoma
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Anaplastic
1
Liposarcoma
1
Leiomyosarcoma
1
Histiocytoma, Malignant Fibrous
1
Eccrine Porocarcinoma
1
Carcinoma, Signet Ring Cell
1
Carcinoma, Merkel Cell
1
Carcinoma, Ductal, Breast
1
Carcinoma, Ductal
1
Carcinoma, Basosquamous
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Adenocarcinoma, Papillary
1
Interventions
pembrolizumab
11
Cisplatin
11
Carboplatin
7
Radiotherapy
6
Cetuximab
6
Docetaxel
5
Surveys and Questionnaires
3
Radiotherapy, Intensity-Modulated
3
Paclitaxel
3
Nivolumab
3
Cyclophosphamide
3
fludarabine
2
cemiplimab
2
atezolizumab
2
aldesleukin
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiation
2
Magnetic Resonance Spectroscopy
2
Fluorouracil
2
Drug Therapy
2
vistusertib
1
toripalimab
1
sitravatinib
1
palbociclib
1
osimertinib
1
olaparib
1
niraparib
1
lenvatinib
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Squamous Cell
×
talimogene laherparepvec
×
90 days
×
Clear all
No trials found.